About Boditech Med
Boditech Med is a company based in Chuncheon (South Korea) founded in 1998. The company has 532 employees as of December 31, 2024. Boditech Med has completed 1 acquisition, including Immunostics. Boditech Med offers products and services including ichroma™ Diagnostic Kits and AFIAS Diagnostic Analyzer.
- Headquarter Chuncheon, South Korea
- Employees 532 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Boditech Med, Inc.
-
Annual Revenue
$93.67 M (USD)2.94as on Dec 31, 2024
-
Net Profit
$18.48 M (USD)5.06as on Dec 31, 2024
-
EBITDA
$23.44 M (USD)-1.25as on Dec 31, 2024
-
Latest Funding Round
$13.22 M (USD), Post-IPO
Apr 14, 2017
- Investors
-
Employee Count
532
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Boditech Med
Boditech Med is a publicly listed company on the KRX with ticker symbol 206640 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Boditech Med
Boditech Med offers a comprehensive portfolio of products and services, including ichroma™ Diagnostic Kits and AFIAS Diagnostic Analyzer.
Kits for rapid detection of infectious diseases like dengue
Automated analyzer for blood sample testing in diagnostics
Funding Insights of Boditech Med
Investors in Boditech Med
Boditech Med has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include DAOL Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund
|
Locked | Locked | Locked |
Investor details for Boditech Med
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Boditech Med
Boditech Med has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Immunostics.
Investment portfolio details for Boditech Med
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Rapid diagnostic tests, kits, and reagents for diseases are developed.
|
Locked | Locked | 1983 | Locked |
Complete acquisition details for Boditech Med
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Boditech Med
Detailed financials for Boditech Med
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Boditech Med Comparisons
Peer comparison for Boditech Med
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Boditech Med
Detailed competitors of Boditech Med
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Boditech Med
Complete news archive for Boditech Med
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boditech Med
Boditech Med was founded in 1998 and raised its 1st funding round 19 years after it was founded.
Boditech Med is headquartered in Chuncheon, South Korea. It is registered at Chuncheon, Gangwon, South Korea.
As of Dec 31, 2024, the latest employee count at Boditech Med is 532.
Annual revenue of Boditech Med is $93.67M as on Dec 31, 2024.
Boditech is focussed on developing in vitro diagnostics instruments and reagents. It is primarily developing two products ichroma, a portable fluorescence scanning instrument for measuring the concentration of target analytes in human blood, urine and other specimens which will be properly processed in accordance with the appropriate Immunoassay Test procedures and hemochroma plus, a hand-held device to measure the concentration of total hemoglobin in the blood. It is also working on a wider range of diagnostic biomarkers and automated analyzers. The available tests include cardiac markers, HbA1c, Tumor markers, microalbumin, infection, rheumatoid arthritis, Vitamin D, and Ferritin.
Boditech Med offers ichroma™ Diagnostic Kits and AFIAS Diagnostic Analyzer.
Yes, Boditech Med is publicly traded on KRX under the ticker symbol 206640.
Boditech Med has made 1 acquisition, including Immunostics.
Boditech Med has 1 investor. Key investors include DAOL Investment.
The ticker symbol of Boditech Med is 206640 on KRX.